Insider trading

Period: 120 months Stock: DMRA Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
25 Sep 2026
Jarrett Jennifer Director, President and CEO
Bought
$252.88K 12,500 at 20.23
2.5%
First buy on file
6 Jul 2026
Winslow Garrett General Counsel
Sold at will
$7.35K 245 at 29.98
9.7%
Not planned
2 Jan 2026
Schambye Hans T. Chief Executive Officer
Sold at will
$14.97K 700 at 21.38
13.0%
Not planned
2 Jan 2026
Winslow Garrett General Counsel
Sold at will
$5.45K 255 at 21.38
12.1%
Not planned
2 Jan 2026
Firmani Lori Chief Financial Officer
Sold at will
$2.89K 135 at 21.41
12.7%
Not planned
3 Jul 2025
Schambye Hans T. Chief Executive Officer
Sold at will
$2.48K 735 at 3.38
15.5%
Not planned
3 Jul 2025
Winslow Garrett General Counsel
Sold at will
$881.40 260 at 3.39
15.4%
Not planned
3 Jul 2025
Firmani Lori Interim CFO
Sold at will
$498.33 147 at 3.39
17.5%
Not planned
3 Jan 2025
Schambye Hans T. Chief Executive Officer
Sold at will
$7.51K 1,341 at 5.60
28.3%
Not planned
3 Jan 2025
Winslow Garrett General Counsel
Sold at will
$2.64K 471 at 5.60
31.8%
Not planned
3 Jan 2025
Firmani Lori Interim CFO
Sold at will
$1.47K 261 at 5.63
36.0%
Not planned
15 Aug 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$617.01K 822,680 at 0.75
89.4%
Sold half or more
31 Jul 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$628.20K 209,400 at 3.00
60.7%
Sold half or more
25 Jul 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$114.46K 39,200 at 2.92
19.5%
Not planned
13 Jul 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$467.28K 194,700 at 2.40
53.4%
Sold half or more
17 Apr 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$25.79K 13,089 at 1.97
6.8%
Not planned
14 Apr 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$77.09K 41,446 at 1.86
18.7%
Not planned
13 Apr 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$25.38K 13,946 at 1.82
7.1%
Not planned
12 Apr 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$4.28K 2,363 at 1.81
1.3%
Not planned
11 Apr 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$25.38K 13,946 at 1.82
7.1%
Not planned
10 Apr 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$91.70K 51,228 at 1.79
21.6%
Not planned
6 Apr 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$19.33K 9,665 at 2.00
4.9%
Not planned
5 Apr 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 3×
$202.66K 92,965 at 2.18
33.2%
Not planned
Showing 1–23 of 23.